Throughout our clinical trials, we employ a diverse range of technologies to thoroughly evaluate the effectiveness and efficiency of vaccines and immunomodulators.
These include laboratory analyzers, flow cytometry, polymerase chain reaction (PCR), spectrophotometers, electronic medical devices, and clinical laboratory equipment.
Vaccines tested through clinical trials using the basis of ClinicalTrialsUA sites demonstrated their efficacy in controlling diseases and preventing their spread.
These vaccines have significantly contributed to improving people’s health, enhancing their quality of life, and fostering the development of herd immunity.
ClinicalTrialsUA successfully conducts clinical trials on immunization, a proven strategy for combating life-threatening infectious diseases.
ClinicalTrialsUA significantly contributes to vaccine clinical trials by leveraging cutting-edge technologies. This ensures that only high-quality and thoroughly tested vaccines are introduced to the market.
According to the World Health Organization (WHO), immunization prevents 2 to 3 million deaths every year.
It is one of the most cost-effective investments in healthcare, employing proven strategies to make immunization accessible even to the most remote and vulnerable populations.
That’s why the ClinicalTrialsUA Center has prioritized this direction as one of its main focuses in practice.
Immunization, commonly known as vaccination, involves artificially triggering the body’s immune system to create a protective response against a specific disease.
This process includes administering a vaccine, which is a prepared, inactivated, or weakened agent. This prompts an immune response without causing the actual disease.
Vaccines stand out as one of the most groundbreaking achievements in the history of medicine and science.
They play a crucial role in maintaining the health and well-being of the population, achieving the following:
- preventing numerous diseases
- controlling epidemics
- improving global health
- building herd immunity
- overcoming and eradicating certain diseases
All vaccines proposed for registration and use in Ukraine undergo comprehensive preclinical and phase I and II clinical studies to establish their quality and safety for patients.
This process ensures that the safety of these vaccines has been thoroughly verified.When registering vaccines in Ukraine, an evaluation is conducted to assess the benefit-to-risk ratio.
Only if the ratio is positive, such vaccines are recommended for registration.
ClinicalTrialsUA consistently follows international standards and recommendations in all its clinical trials.
Qualified experts in the fields of Vaccination and Virology supervise each stage of the clinical trials process.
